{
 "ticker": "MDEV",
 "name": "First Trust Indxx Medical Devices ETF",
 "issuer": "First Trust",
 "desk": "themes",
 "url": "https://etfiq.com/funds/MDEV",
 "html": "https://etfiq.com/funds/MDEV",
 "markdown": "https://etfiq.com/funds/MDEV.md",
 "as_of": "2026-09-11",
 "verdict": "MDEV holds 50 stocks, and 54% of its weight is outside the S&P 500.",
 "key_facts": [
  {
   "key": "already_in_the_s_p_500",
   "label": "Already in the S&P 500",
   "value": "46.4%",
   "source": null,
   "as_of": "2026-09-11",
   "sentence": "MDEV, already in the S&P 500: 46.4%, as of Sep 11, 2026."
  },
  {
   "key": "active_share_vs_the_s_p_500",
   "label": "Active share vs the S&P 500",
   "value": "98.0%",
   "source": null,
   "as_of": "2026-09-11",
   "sentence": "MDEV, active share vs the S&P 500: 98.0%, as of Sep 11, 2026."
  },
  {
   "key": "top_ten_holdings",
   "label": "Top ten holdings",
   "value": "26.3%",
   "source": null,
   "as_of": "2026-09-11",
   "sentence": "MDEV, top ten holdings: 26.3%, as of Sep 11, 2026."
  },
  {
   "key": "total_return_1_year",
   "label": "Total return, 1 year",
   "value": "\u22123.1%",
   "source": null,
   "as_of": "2026-09-11",
   "sentence": "MDEV, total return, 1 year: \u22123.1%, as of Sep 11, 2026."
  },
  {
   "key": "net_assets",
   "label": "Net assets",
   "value": "$2m",
   "source": "SEC filing, whole fund, as filed for Jun 30, 2026",
   "as_of": "2026-09-11",
   "sentence": "MDEV, net assets: $2m (SEC filing, whole fund, as filed for Jun 30, 2026)."
  },
  {
   "key": "expense_ratio",
   "label": "Expense ratio",
   "value": "0.70%",
   "source": "485BPOS XBRL, Jul 29, 2026",
   "as_of": "2026-09-11",
   "sentence": "MDEV, expense ratio: 0.70% (485BPOS XBRL, Jul 29, 2026)."
  }
 ],
 "fields": [
  {
   "key": "theme",
   "label": "Theme",
   "value": "Therapeutics and medical devices",
   "source": "ETFIQ, editorial"
  },
  {
   "key": "launched",
   "label": "Launched",
   "value": "Jun 23, 2021",
   "source": null
  },
  {
   "key": "already_in_the_s_p_500_by_weight",
   "label": "Already in the S&P 500, by weight",
   "value": "46.4%",
   "source": "ETFIQ"
  },
  {
   "key": "active_share_vs_the_s_p_500",
   "label": "Active share vs the S&P 500",
   "value": "98.0%",
   "source": "ETFIQ"
  },
  {
   "key": "already_in_the_nasdaq_100_by_weight",
   "label": "Already in the Nasdaq-100, by weight",
   "value": "5.8%",
   "source": "ETFIQ"
  },
  {
   "key": "active_share_vs_the_nasdaq_100",
   "label": "Active share vs the Nasdaq-100",
   "value": "99.1%",
   "source": "ETFIQ"
  },
  {
   "key": "top_ten_holdings_weight",
   "label": "Top ten holdings weight",
   "value": "26.3%",
   "source": null
  },
  {
   "key": "holdings",
   "label": "Holdings",
   "value": "50",
   "source": null
  },
  {
   "key": "holdings_as_of",
   "label": "Holdings as of",
   "value": "Sep 10, 2026",
   "source": "the issuer\u2019s daily file"
  },
  {
   "key": "top_holdings",
   "label": "Top holdings",
   "value": "WuXi AppTec Co., Ltd. (Class H) 2.9%, Demant A/S 2.8%, Baxter International Inc. 2.7%, Revvity, Inc. 2.6%, West Pharmaceutical Services, Inc. 2.6%, Sysmex Corporation 2.6%, Bio-Rad Laboratories, Inc. (Class A) 2.6%, DexCom, Inc. 2.6%, Merit Medical Systems, Inc. 2.5%, Olympus Corporation 2.5%",
   "source": null
  },
  {
   "key": "net_assets",
   "label": "Net assets",
   "value": "$2m",
   "source": "SEC filing, whole fund, as filed for Jun 30, 2026"
  },
  {
   "key": "below_its_all_time_high",
   "label": "Below its all-time high",
   "value": "\u221228.5%",
   "source": "ETFIQ"
  },
  {
   "key": "expense_ratio",
   "label": "Expense ratio",
   "value": "0.70%",
   "source": "485BPOS XBRL, Jul 29, 2026"
  },
  {
   "key": "fee_for_the_part_that_differs_from_the_s_p_500_active_expense_ratio",
   "label": "Fee for the part that differs from the S&P 500, active expense ratio",
   "value": "0.71%",
   "source": "ETFIQ"
  },
  {
   "key": "closest_funds_by_holdings_overlap",
   "label": "Closest funds by holdings overlap",
   "value": "IHI 31%, HTEC 30%, AGNG 19%, GDOC 18%, LGHT 17%",
   "source": null
  }
 ],
 "periods": [
  {
   "window": "3 months",
   "Total return": "+6.5%",
   "S&P 500": "+3.3%",
   "Gap to S&P 500": "+3.2 pts",
   "Gap to Nasdaq-100": "+7.3 pts"
  },
  {
   "window": "6 months",
   "Total return": "+6.4%",
   "S&P 500": "+16.0%",
   "Gap to S&P 500": "\u22129.6 pts",
   "Gap to Nasdaq-100": "\u221214.3 pts"
  },
  {
   "window": "1 year",
   "Total return": "\u22123.1%",
   "S&P 500": "+17.5%",
   "Gap to S&P 500": "\u221220.6 pts",
   "Gap to Nasdaq-100": "\u221226.0 pts"
  },
  {
   "window": "3 years",
   "Total return": "+6.2%",
   "S&P 500": "+77.9%",
   "Gap to S&P 500": "\u221271.7 pts",
   "Gap to Nasdaq-100": "\u221288.9 pts"
  },
  {
   "window": "Since launch",
   "Total return": "\u221220.6%",
   "S&P 500": "+93.5%",
   "Gap to S&P 500": "\u2212114.2 pts",
   "Gap to Nasdaq-100": "\u2212132.4 pts"
  }
 ],
 "questions": [
  {
   "q": "How much of MDEV is in S&P 500 companies?",
   "a": "By its holdings published by its issuer for Sep 10, 2026, 46% of MDEV by weight is stocks the S&P 500 already holds. Its active share against the index is 98%, so that share is the part doing something different."
  },
  {
   "q": "What does MDEV hold?",
   "a": "50 positions as published by its issuer for Sep 10, 2026, with the top ten at 26% of the fund. The largest are WuXi AppTec Co., Ltd. (Class H) at 2.9%, Demant A/S at 2.8%, Baxter International Inc. at 2.7%."
  },
  {
   "q": "Has MDEV beaten the S&P 500?",
   "a": "Over the year to Sep 11, 2026 MDEV returned \u22123.1% with distributions reinvested, against +17.5% for the S&P 500, so it finished behind the index by 20.6 points."
  },
  {
   "q": "What does MDEV cost?",
   "a": "The prospectus expense ratio is 0.70% a year. Because 98% of the fund differs from the S&P 500, the fee on that differing part works out at 0.71%."
  }
 ],
 "generated": "2026-09-13",
 "license": "Free to use with attribution. ETFIQ (etfiq.com)."
}